tirzepatide and cancer Possible pro-oncogenic effect of (TRZD) on the pancreas, Weight loss injections and cancer:

You do not need special or accelerated monitoring simply because you are on a GLP-1 receptor agonist

Christianne de Faria Coelho e outros

(2023) Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes Ferhatbegovi, Lamija et al

D.DixonJ

The 20-30 minute half-life is not a bug, but a feature that allows localized and site-specific growth without prolonged systemic exposure

Its wise to keep in mind that while the medications can help a person lose weight, overweight and obesity are complex diseases, and lifestyle modifications like diet and exercise are needed to maximize successful long-term weight management and overall health